HQH News and Press, Tekla Healthcare Investors From 07/03/23

2023-07-03 15:45:45 ET Summary Tekla Healthcare Investors, a closed-end fund, focuses on the biotech subsector of healthcare, leading to potential volatility but also potential for high returns. The fund's deep discount presents an opportunity for investors after a down year for b...

PHILADELPHIA, PA / ACCESSWIRE / June 20, 2023 / abrdn plc today announced that its U.S. subsidiary abrdn Inc. has entered into an agreement to acquire the healthcare fund management capabilities of Tekla Capital Management LLC (Tekla), a global specialist healthcare investment adviser based in B...

Tekla Capital Management LLC (Tekla) announced today that it has entered into an agreement with abrdn Inc. for a strategic transaction involving four NYSE-listed healthcare & biotech thematic closed-end funds (the Funds), totaling $3.1 bn in assets under management. 1 Under the propos...

2023-05-15 11:23:46 ET Tekla Healthcare Investors ( NYSE: HQH ) declares $0.40/share quarterly dividend , -4.8% decrease from prior dividend of $0.42. Forward yield 9.12% Payable June 30; for shareholders of record May 25; ex-div May 24. See HQH Dividend ...

2023-05-10 07:35:00 ET Summary Charlie Munger, vice chairman of Berkshire Hathaway Inc., brings a wealth of investment wisdom, priceless for those who seek to learn. Everyone has different requirements and priorities; we will mimic, but not mirror, his investing style. We disc...

2023-05-10 03:28:34 ET Summary You want exposure to the healthcare sector in your retirement portfolio. HQH fund has a 35-year track of outperforming and returning value to investors. It comes with an attractive discount not seen since March 2020. Tekla Healthcare In...

2023-04-16 14:00:00 ET Summary There are generally two separate issues with respect to leaving an estate – spouses and everyone else. Spouses should generally plan to generate enough income to sustain the longer-lived spouse – this means that the spouse who passes fi...

2023-04-12 02:26:28 ET Summary The White House's announcement on drug price caps caused a significant drop in biopharma stocks during Q1 2023. The impact of drug pricing-related caps and pressure will likely be limited, and the industry is expected to adapt and find new revenue st...

2023-04-10 08:00:00 ET Summary Legendary fund manager John Neff was a fan of big yields. Investment success does not require glamour stocks or bull markets. - John Neff. Mr. Neff saw healthy dividend income as a defense against market swings. We are buying 2 deeply discoun...

2023-03-09 05:23:39 ET Summary First Trust CEF Income Opportunity ETF is an actively managed fund of funds. It has outperformed its competitors YYY and PCEF since 2016. Distribution growth has outpaced inflation, but share price has lagged it. The main issues of this fund ...